References
- Staatz CE, Taylor PJ, Lynch SV, et al. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Liver Transpl 2004 Apr;10(4):506–12.
- O’Seaghdha CM, McQuillan R, Moran AM, et al. Higher tacrolimus trough levels on days 2–5 post-renal transplant are associated with reduced rates of acute rejection. Clin Transplant 2009 Aug;23(4):462–8.
- Liu F, Li Y, Lan X, Wei YG, et al. Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts. World J Gastroenterol 2009 Aug 21;15(31):3931–6.
- Ye F, Ying-Bin X, Yu-Guo W, et al. Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis. J Heart Lung Transplant 2009 Jan; 28(1): 58–66.
- Gruessner RW, Kandaswamy R, Humar A. Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation. Transplantation 2005 May 15; 79(9):1184–9.
- Celik MR, Lederer DJ, Wilt J, et al. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study. J Heart Lung Transplant 2009 Jul;28(7):697–703. Epub 2009 May 13.
- Marchewka Z, Kuźniar J, Zynek-Litwin et al. Kidney graft function in long-term cyclosporine and tacrolimus treatment: comparative study with nephrotoxicity markers. Transplant Proc 2009 Jun;41(5):1660–5.
- Videla CO. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy. Transplant Proc 2009 Jul–Aug;41(6):2659–63.
- Staatz CE, Taylor PJ, Lynch SV, et al. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Liver Transplant 2004 Apr;10(4):506–12.
- Woodside KJ, Nichols SD, Hunter GC, et al. Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profile. Transplant Proc 2005 May;37(4):1877–9.
- Basić-Jukić N, Jurić I, Kes P, et al. [Arterial hypertension in renal transplant recipients]. Acta Med Croatica 2007 Apr;61(2):171–6
- Kim HC, Hwang EA, Han SY. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center. Transplant Proc 2004 Sep;36(7):2082–3.
- Al Masri O, Fathallah W, Quader S., et al. Recovery of tacrolimus-associated brachial neuritis after conversion to everolimus in a pediatric renal transplant recipient—case report and review of the literature. Pediatr Transplant 2008 Dec;12(8):914–7. Epub 2008 May 23.
- Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl 2005 Aug;11(8):881–90.
- van Hooff JP, Christiaans MH, van Duijnhoven EM. Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 2005 Jun 15;79(11):1465–9.
- Tory R, Sachs-Barrable K, Goshko CB, et al. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations. Transplantation 2009 Jul 15;88(1):62–8.
- Forgacs B, Merhav HJ, Lappin J, et al. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Transplant Proc 2005 May; 37(4):1912–4.
- Mazali FC, Lalli CA, Alves-Filho G, et al. Posttransplant diabetes mellitus: incidence and risk factors. Transplant Proc 2008 Apr;40(3):764–6.
- Salifu MO, Tedla F, Aytug S, et al. Posttransplant diabetes and hypertension: pathophysiologic insights and therapeutic rationale. Curr Diab Rep 2008 Jun;8(3):221–7.
- Jardine AG. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Transpl Int 2005 Apr;18(4):379–84.
- Burroughs TE, Lentine KL, Takemoto SK, et al. Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. Clin J Am Soc Nephrol 2007 May;2(3):517–23.
- Li QY, Li F, Sun JH, Chi YY, et al. Mechanisms of diabetes mellitus induced with FK506 in SD rats models. Immunopharmacol Immunotoxicol 2009 Jul 28. [Epub ahead of print]
- Zhang M, Lv XY, Li J, et al. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008 Jan;2008:704045.
- Juan CC, Shen YW, Chien Y, et al. Insulin infusion induces endothelin-1-dependent hypertension in rats. Am J Physiol Endocrinol Metab 2004 Nov;287(5):E948–54. Epub 2004 Jun.